Covestor LTD Arrowhead Pharmaceuticals, Inc. Transaction History
Covestor LTD
- $155 Million
- Q2 2024
A detailed history of Covestor LTD transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 452 shares of ARWR stock, worth $10,509. This represents 0.01% of its overall portfolio holdings.
Number of Shares
452
Previous 207
118.36%
Holding current value
$10,509
Previous $6,000
100.0%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$365 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$284 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$207 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$136 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$96.2 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.46B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...